Neurocrine Biosciences NBIX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $274.5M+35.8% | $721M+199% | $348.2M-2.5% | $272M+84.2% | $202.1M-50.0% | ||
| $1.05B+40.1% | $767.4M-9.0% | $774.6M-11.9% | $711.6M-20.9% | $749.4M-8.0% | ||
| $2.44B+48.7% | $2.52B+46.3% | $2.16B+15.0% | $1.75B+4.7% | $1.64B-9.0% | ||
| $90.9M+4.5% | $89.8M+8.7% | $97.3M+21.6% | $91.7M+14.5% | $87M+15.5% | ||
| $4.91B+33.0% | $4.63B+24.5% | $4.27B+20.7% | $3.89B+17.7% | $3.69B+6.2% | ||
| $773M+62.7% | $674.3M+46.1% | $584.3M+48.8% | $489.5M+36.5% | $475.2M+13.9% | ||
| $831.7M+59.1% | $743.4M+46.4% | $638M+48.5% | $546.3M+37.1% | $522.9M-26.7% | ||
| $1.5B+30.1% | $1.38B+22.1% | $1.26B+54.7% | $1.2B+50.2% | $1.15B+6.0% | ||
| 220M0.0% | 220M+219,900% | 220M0.0% | 220M0.0% | 220M0.0% | ||
| $589.6M+11,225% | $447.7M+1,433% | $294M+263% | $84.5M+274% | -$5.3M+95.3% | ||
| $3.41B+34.4% | $3.25B+25.6% | $3B+10.5% | $2.69B+7.4% | $2.54B+6.3% | ||
| $4.91B+33.0% | $4.63B+24.5% | $4.27B+20.7% | $3.89B+17.7% | $3.69B+6.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Neurocrine Biosciences's total assets?
- Neurocrine Biosciences (NBIX) holds $4.9B in total assets, up 33.0% year over year.
- How much debt does Neurocrine Biosciences have?
- Neurocrine Biosciences carries $463.5M in total debt against $3.4B of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does Neurocrine Biosciences have?
- Neurocrine Biosciences holds $274.5M in cash and equivalents.
- Can Neurocrine Biosciences cover its short-term obligations?
- Its current ratio is 2.93 — current assets exceed current liabilities.
- Where does Neurocrine Biosciences's balance sheet data come from?
- Every line is extracted from Neurocrine Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
